Recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease: A scoping review

医学 阿达木单抗 英夫利昔单抗 Golimumab公司 阿巴塔克普 阿纳基纳 依那西普 类风湿性关节炎 托法替尼 内科学 怀孕 托珠单抗 强直性脊柱炎 磺胺吡啶 羟基氯喹 物理疗法 美罗华 重症监护医学 疾病 生物 遗传学 2019年冠状病毒病(COVID-19) 淋巴瘤 溃疡性结肠炎 传染病(医学专业)
作者
Athena Chin,Alice Terrett,Mi‐Hye Kwon,Samuel Whittle,Catherine Hill
出处
期刊:Arthritis Care and Research [Wiley]
标识
DOI:10.1002/acr.25558
摘要

Objective Autoimmune rheumatic diseases commonly affect individuals of childbearing age, with historically increased adverse pregnancy outcomes in this group. The advent of disease‐modifying anti‐rheumatic drugs (DMARDs) has fostered more suitable conditions for pregnancy; however, this is accompanied by challenges in ensuring safe use in reproductive health. The aim of this review is to compare existing guideline recommendations for the use of DMARDs in pregnancy and reproductive health for patients with rheumatic disease. Methods A scoping review was performed with Medline and EMBASE, in addition to a hand search, to identify guidelines published since 2014 by academic societies in rheumatology that addressed management of DMARDs in pregnancy in any of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus. Conventional synthetic DMARDs (csDMARDS; methotrexate, sulfasalazine, leflunomide, hydroxychloroquine), biologic DMARDs (bDMARDs; adalimumab, etanercept, infliximab, golimumab, certolizumab, abatacept, tocilizumab, rituximab, anakinra) and targeted synthetic DMARDs (tsDMARDs; tofacitinib, baricitinib, upadacitinib) were targeted. Two authors performed data extraction in duplicate. Results 18 guidelines were included. Recommendations for DMARD use in pre‐conception were present in 10 (56%), lactation in 12 (67%) and male fertility in 6 (33%). 13 (72%) guidelines included recommendations for csDMARDs, 13 (72%) bDMARDs and 5 (28%) tsDMARDs. There was moderate evidence supporting relatively uniform csDMARD recommendations, compared to minimal evidence for b/tsDMARD use with variable recommendations. Conclusion There is heterogeneity in formulation of guidelines on the use of DMARDs in pregnancy. Recommendations for csDMARDs were similar between guidelines. There was significant variability in recommendations for b/tsDMARD use, reflecting current minimal literature in this area.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LYL完成签到,获得积分10
1秒前
zhouleiwang完成签到,获得积分10
1秒前
Akim应助catalysisman采纳,获得10
2秒前
Christina完成签到 ,获得积分10
3秒前
mikasa完成签到,获得积分10
3秒前
帅气的绿凝完成签到,获得积分10
3秒前
Grace完成签到 ,获得积分10
4秒前
出海流浪发布了新的文献求助10
4秒前
amber完成签到,获得积分10
4秒前
洞若观烟火完成签到,获得积分10
5秒前
7Steven7完成签到 ,获得积分10
6秒前
BEIBEI完成签到,获得积分10
6秒前
大肉猪完成签到,获得积分10
6秒前
HH完成签到,获得积分10
6秒前
淡然的大雁完成签到,获得积分10
7秒前
7秒前
枚青青发布了新的文献求助20
7秒前
8秒前
XQQDD完成签到,获得积分0
8秒前
开心完成签到,获得积分10
8秒前
心念完成签到 ,获得积分10
9秒前
9秒前
胖胖橘完成签到 ,获得积分10
9秒前
zy完成签到,获得积分10
9秒前
222完成签到,获得积分10
11秒前
11秒前
考马斯亮蓝完成签到 ,获得积分10
11秒前
11秒前
迷路胡萝卜完成签到,获得积分10
12秒前
小周完成签到 ,获得积分10
12秒前
甜味白开水完成签到,获得积分10
12秒前
大壮完成签到,获得积分10
12秒前
Cheryl完成签到,获得积分10
13秒前
赵芳发布了新的文献求助10
13秒前
科目三应助XQQDD采纳,获得10
13秒前
zzy发布了新的文献求助10
14秒前
momo完成签到 ,获得积分10
14秒前
小明完成签到,获得积分10
14秒前
化合物来发布了新的文献求助10
15秒前
兰禅子发布了新的文献求助10
15秒前
高分求助中
Adhesion Science: Principles & Practice 1234
Signals, Systems, and Signal Processing 610
Burger's Medicinal Chemistry and Drug Discovery 400
A Step-by-Step Guide to Qualitative Data Coding 2nd Edition 400
Impact of Storage Orientation and Duration on Prefilled Syringe Performance: Break-Loose and Glide Forces, and Injection Time Across Multiple Time Points 360
Programming for Chemical Engineers Using C, C++, and MATLAB 300
Upland Kenya wild flowers and ferns: a flora of the flowers, ferns, grasses, and sedges of highland Kenya 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6664434
求助须知:如何正确求助?哪些是违规求助? 8414206
关于积分的说明 17986334
捐赠科研通 5869625
什么是DOI,文献DOI怎么找? 2975436
邀请新用户注册赠送积分活动 1951357
关于科研通互助平台的介绍 1877831